Preventive Therapy in Migraine: Payer Considerations

Jill Dehlin, RN; Peter Goadsby, MD, PhD; Peter L. Salgo, MD; and Malaika Stoll, MD, MPA, consider the long-term costs associated with prescription drug therapies available for preventive therapy of migraine and review current coverage criteria.